190 related articles for article (PubMed ID: 9108445)
1. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
Kaplan O; Kushnir T; Askenazy N; Knubovets T; Navon G
Cancer Res; 1997 Apr; 57(8):1452-9. PubMed ID: 9108445
[TBL] [Abstract][Full Text] [Related]
2. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
Winter PM; Poptani H; Bansal N
Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
[TBL] [Abstract][Full Text] [Related]
3. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
[TBL] [Abstract][Full Text] [Related]
4. An ex vivo model for the study of tumor metabolism by nuclear magnetic resonance: characterization of the phosphorus-31 spectrum of the isolated perfused Morris hepatoma 7777.
Graham RA; Brown TR; Meyer RA
Cancer Res; 1991 Feb; 51(3):841-9. PubMed ID: 1988124
[TBL] [Abstract][Full Text] [Related]
5. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.
Kaplan O; Navon G; Lyon RC; Faustino PJ; Straka EJ; Cohen JS
Cancer Res; 1990 Feb; 50(3):544-51. PubMed ID: 2297696
[TBL] [Abstract][Full Text] [Related]
6. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.
Mardor Y; Kaplan O; Sterin M; Ruiz-Cabello J; Ash E; Roth Y; Ringel I; Cohen JS
Cancer Res; 2000 Sep; 60(18):5179-86. PubMed ID: 11016646
[TBL] [Abstract][Full Text] [Related]
8. Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy.
Kiessling F; Huber PE; Grobholz R; Heilmann M; Meding J; Lichy MP; Fink C; Krix M; Peschke P; Schlemmer HP
Invest Radiol; 2004 Jan; 39(1):34-44. PubMed ID: 14701987
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
10. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
11. Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy.
Naruse S; Hirakawa K; Horikawa Y; Tanaka C; Higuchi T; Ueda S; Nishikawa H; Watari H
Cancer Res; 1985 Jun; 45(6):2429-33. PubMed ID: 3986784
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster.
Chang BK; Gutman R
Cancer Res; 1982 Jul; 42(7):2666-70. PubMed ID: 6805945
[TBL] [Abstract][Full Text] [Related]
13. [Proton-magnetic resonance spectroscopy (1H-MRS) of human plasma obtained from patients with various cancer--new detection method for common cancer].
Itoh YH; Kikuchi A; Kobayashi M; Oguri T
Rinsho Byori; 1995 Dec; 43(12):1279-83. PubMed ID: 8569041
[TBL] [Abstract][Full Text] [Related]
14. Method for determination of intracellular sodium in perfused cancer cells by 23Na nuclear magnetic resonance spectroscopy.
Hansen LL; Rasmussen J; Friche E; Jaroszewski JW
Anal Biochem; 1993 Nov; 214(2):506-10. PubMed ID: 8109741
[TBL] [Abstract][Full Text] [Related]
15. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O
Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic amylase as a tumour marker for pancreatic cancer.
Hilmy AM; Kandeel KM; Selim NM
Arch Geschwulstforsch; 1984; 54(6):475-82. PubMed ID: 6084495
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic and metabolic characterization of orthotopic rat prostate carcinomas using dynamic MRI and proton magnetic resonance spectroscopy].
Kiessling F; Lichy M; Grobholz R; Heilmann M; Huber PE; Meding J; Peschke P; Kauczor HU; Schlemmer HP
Radiologe; 2003 Jun; 43(6):489-94. PubMed ID: 12827264
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
Ouyang N; Williams JL; Tsioulias GJ; Gao J; Iatropoulos MJ; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2006 Apr; 66(8):4503-11. PubMed ID: 16618778
[TBL] [Abstract][Full Text] [Related]
20. Metabolic alterations in focally activated primary somatosensory cortex of alpha-chloralose-anesthetized rats measured by 1H MRS at 11.7 T.
Xu S; Yang J; Li CQ; Zhu W; Shen J
Neuroimage; 2005 Nov; 28(2):401-9. PubMed ID: 16182571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
